Bone Marrow TransplantationCyclophosphamideTransplantation, HomologousBone MarrowGraft vs Host DiseaseHematopoietic Stem Cell TransplantationBone Marrow CellsHistocompatibilityGraft SurvivalTransplantation ConditioningHistocompatibility TestingTissue DonorsKidney TransplantationHematologic NeoplasmsImmunosuppressive AgentsGraft RejectionLeukemiaTransplantation, AutologousTransplantation ChimeraTreatment OutcomeBone and BonesWhole-Body IrradiationHLA AntigensSevere Combined ImmunodeficiencyHaploidyLymphocyte DepletionRecurrenceTime FactorsHaplotypesRetrospective StudiesAnemia, AplasticCytomegalovirus InfectionsTransplantsFetal TherapiesT-LymphocytesPeripheral Blood Stem Cell TransplantationAcute DiseaseLeukemia, Myeloid, AcuteImmunosuppressionGraft vs Leukemia EffectLymphocyte TransfusionHematopoietic Stem CellsAntilymphocyte SerumLiving DonorsCombined Modality TherapyCyclosporinePrecursor Cell Lymphoblastic Leukemia-LymphomaImmunocompromised HostPostoperative ComplicationsUnrelated DonorsCord Blood Stem Cell TransplantationBone Marrow DiseasesOpportunistic InfectionsDisease-Free SurvivalBusulfanReceptors, KIRBone Marrow PurgingRemission InductionBone RemodelingAntineoplastic Combined Chemotherapy ProtocolsStem Cell TransplantationSurvival RateBone Marrow ExaminationHeart TransplantationAntigens, CD34TransplantationSiblingsFollow-Up StudiesGranulocyte Colony-Stimulating FactorSurvival AnalysisMice, Inbred C57BLHematopoiesisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow NeoplasmsMyeloablative AgonistsN-Acetylgalactosamine-4-SulfataseMycosesCytomegalovirusVidarabineKiller Cells, NaturalTransplantation, IsogeneicLung TransplantationFatal OutcomeHematologic DiseasesCystitisBone DensityLymphoma, Non-HodgkinMethotrexateRadiation ChimeraGanciclovirImmunotherapy, AdoptiveColony-Forming Units AssayVincristineAspergillosisPrednisonePneumonia, ViralImmune ToleranceNuclear FamilyTacrolimusDoxorubicin